Rabbit Polyclonal MAGEA4 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 6 publications. Immunogen corresponding to Recombinant Fragment Protein within Human MAGEA4.
View Alternative Names
MAGE4, MAGEA4, Melanoma-associated antigen 4, Cancer/testis antigen 1.4, MAGE-4 antigen, MAGE-41 antigen, MAGE-X2 antigen, CT1.4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MAGEA4 antibody (AB229011)
Paraffin-embedded human breast cancer tissue stained for MAGEA4 using ab229011 at 1/500 dilution in immunohistochemical analysis.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MAGEA4 antibody (AB229011)
4% paraformaldehyde-fixed A-375 (human malignant melanoma cell line) cells stained for MAGEA4 (green) using ab229011 at 1/500 dilution in ICC/IF.
Nuclear counterstain : Hoechst 33342 (blue).
- WB
Supplier Data
Western blot - Anti-MAGEA4 antibody (AB229011)
12% SDS-PAGE gel.
All lanes:
Western blot - Anti-MAGEA4 antibody (ab229011) at 1/2000 dilution
All lanes:
A549 (human lung carcinoma cell line) whole cell lysate at 30 µg
Predicted band size: 35 kDa
false
- WB
Lab
Western blot - Anti-MAGEA4 antibody (AB229011)
False colour image of Western blot : Anti-MAGEA4 antibody staining at 1/500 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab229011 was shown to bind specifically to MAGEA4. A band was observed at 40 kDa in wild-type A431 cell lysates with no signal observed at this size in MAGEA4 knockout cell line ab273857 (knockout cell lysate ab273811). To generate this image, wild-type and MAGEA4 knockout A431 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
SH-SY5Y cell lysate at 1/500 dilution
Lane 1:
Wild-type A431 cell lysate at 20 µg
Lane 2:
Western blot - Human MAGEA4 knockout A-431 cell lysate (ab273811) at 20 µg
Lane 3:
U-2 OS cell lysate at 20 µg
Lane 4:
Western blot at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 40 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MAGEA4 participates in cellular processes related to cancer progression. Although not part of a multi-protein complex its presence in tumorous tissues suggests a role in modulating cellular mechanisms that favor tumor survival and proliferation. MAGEA4 does not directly interact with other proteins but might affect cellular pathways indirectly contributing to oncogenesis.
Pathways
MAGEA4 influences several cellular mechanisms that are related to cancer development. While it is not a central player in major biological pathways its function relates to processes affecting cell cycle regulation and apoptosis. This connection was observed in studies showing interactions with other cancer-related proteins like p53 suggesting that MAGEA4 can modify responses to apoptotic signals and may interact with or affect the TP53 pathway.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Medicine 102:e33908 PubMed37266606
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 101:e29621 PubMed35839046
2022
Applications
Unspecified application
Species
Unspecified reactive species
European journal of histochemistry : EJH 66: PubMed35736245
2022
Applications
Unspecified application
Species
Unspecified reactive species
European journal of histochemistry : EJH 66: PubMed35448937
2022
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 12: PubMed35328286
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular biology 434:167397 PubMed34896361
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com